You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TARS Sale Disclosure
Lin Elizabeth Yeu · SEC Form 4 · Filed Sep 9, 2026
Sale
Calculated transaction value
$135.15K
Lin Elizabeth Yeu Chief Medical Officer
TARS
Transaction date
Sep 4, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 5 days later
TARS daily price context
Close on/before transaction
$90.78
Sep 4, 2026
First close after public filing
$81.12
Sep 10, 2026
30-day return after filing
-9.81%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,590 shares @ $85
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001842190-26-000011
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.22M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | Sale | Sep 4, 2026 | $457.89K |
| Tarsus Pharmaceuticals, Inc. TARS | Sale | Sep 4, 2026 | $484.74K |
| Tarsus Pharmaceuticals, Inc. TARS Current | Sale | Sep 4, 2026 | $135.15K |
| Tarsus Pharmaceuticals, Inc. TARS | Sale | Sep 4, 2026 | $143.1K |